Reference Interval:
| Drugs Covered and Cutoff Concentrations
| | Drugs/Drug Classes
| Screen
| | Amphetamines
| 30 ng/mL
| | Methamphetamine
| 30 ng/mL
| | Barbiturates
| 75 ng/mL
| | Benzodiazepines
| 75 ng/mL
| | Cannabinoids
| 30 ng/mL
| | Cocaine
| 30 ng/mL
| | Methadone
| 40 ng/mL
| | Opiates
| 30 ng/mL
| | Oxycodone
| 30 ng/mL
| | Phencyclidine
| 15 ng/mL
| | Propoxyphene
| 75 ng/mL
|
|
| Interpretive Data: |
Drugs/Drug classes reported as "Positive" are automatically reflexed to mass spectrometry confirmation/quantitation. An unconfirmed positive immunoassay screen result may be useful for medical purposes but does not meet forensic standards. The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are automatically reflexed to a second, more specific technology (GC/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
For medical purposes only; not valid for forensic use.
See Compliance Statement B: www.aruplab.com/CS
|
| Note: |
Screen-positive specimens are automatically confirmed by GC/MS and/or LC-MS/MS; additional charges may apply.
|
| CPT Code(s): |
80101 x9 (HCPCS:G0431); if positive add appropriate CPT code(s): 82542; 82520; 83925; 83992; 82145; 82205; 80154; 83840; 83925
|
Cross References: |
Pain Management (Drugs of Abuse 9 Panel, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation)
|
